Skip to main content

Table 4 Degree of detection and acceptance of the AEMPS safety alerts in 2016, 2017, and 2018

From: Safer prescription of drugs: impact of the PREFASEG system to aid clinical decision-making in primary care in Catalonia

 

2016

2017

2018

AEMPS alert

Alerts

Alerts accepted

% Accepted

Alerts

Alerts accepted

% Accepted

Alerts

Alerts accepted

% Accepted

"TRIPLE WHAMMY"*

46,020

13,867

30

76,107

18,992

25

73,860

15,988

22

DICLOFENAC

7288

2588

36

5734

1774

31

5137

1511

29

COXIBS

3131

888

28

2535

616

24

2986

644

22

ACECLOFENAC

805

204

25

665

127

19

487

101

21

ESCITALOPRAM

645

204

32

270

95

35

305

72

24

CITALOPRAM

495

189

38

217

67

31

302

104

34

CILOSTAZOL

193

70

36

181

66

36

289

65

22

AGOMELATINE

133

54

41

175

54

31

249

72

29

IVABRADINE

130

51

39

153

56

37

200

48

24

CANAGLIFLOZIN

128

42

33

177

40

23

TRIMETAZIDINE

115

62

54

82

36

44

111

47

42

RALOXIFENE and BAZEDOXIFENE

106

64

60

23

11

48

30

20

67

STRONTIUM RENALATE

53

39

74

21

11

52

22

5

23

ALISKIREN

32

21

66

17

11

65

3

3

100

Total

59,146

18,301

31

86,308

21,958

25

84,158

18,720

22

  1. *Triple Whammy: NSAIDs + RAS inhibitors + diuretics